Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Cathepsin B modulates microglial migration and phagocytosis of amyloid β in Alzheimer’s disease through PI3K-Akt signaling
    Published on 2024-09-20
    1 year ago
  • Role of dorsal striatum circuits in relapse to opioid seeking after voluntary abstinence
    Published on 2024-09-19
    1 year ago
  • Role of serotonin neurons in the dorsal raphe nucleus in heroin self-administration and punishment
    Published on 2024-09-19
    1 year ago
  • Dopamine transmission at D1 and D2 receptors in the nucleus accumbens contributes to the expression of incubation of cocaine craving
    Published on 2024-09-19
    1 year ago
  • Memory engram stability and flexibility
    Published on 2024-09-18
    1 year ago
  • The anxiogenic drug yohimbine is a reinforcer in male and female rats
    Published on 2024-09-17
    1 year ago
  • In Memoriam: Burton M. Angrist, MD
    Published on 2024-09-17
    1 year ago
« Previous 1 … 41 42 43 44 45 … 143 Next »
Journal of Psychopharmacology
  • Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview
    Published on 2023-11-08
    2 years ago
  • The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review
    Published on 2023-11-08
    2 years ago
  • The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies
    Published on 2023-10-31
    2 years ago
  • Psychological and physiological effects of extended DMT
    Published on 2023-10-28
    2 years ago
  • Clinical quandaries in psychotic disorders: the road is long, with many a winding turn
    Published on 2023-10-16
    2 years ago
  • Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats
    Published on 2023-10-16
    2 years ago
  • Second International Consensus Study of Antipsychotic Dosing (ICSAD-2)
    Published on 2023-10-16
    2 years ago
« Previous 1 … 41 42 43 44 45 … 134 Next »
European Neuropsychopharmacology
  • Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia
    Published on 2023-10-21
    2 years ago
  • Infection-associated chronic disability: A transdiagnostic and translational opportunity for neuroscience
    Published on 2023-10-20
    2 years ago
  • Do epidemiologists choose the right tools to explore the impact of mental disorders over time?
    Published on 2023-10-20
    2 years ago
  • Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality
    Published on 2023-10-20
    2 years ago
  • Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer’s disease patients
    Published on 2023-10-20
    2 years ago
  • Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis
    Published on 2023-10-20
    2 years ago
  • Methodological concerns in psychedelic research: The issues of nonequivalent psychological support and generalizability
    Published on 2023-10-20
    2 years ago
« Previous 1 … 41 42 43 44 45 … 153 Next »

   Pharma Pub